USA-based Kailera Therapeutics today announced its launch as a clinical-stage biopharmaceutical company focused on advancing a broad pipeline of next-generation therapies for the treatment of obesity and related conditions. 1 October 2024
French specialty pharma group Ipsen (Euronext: IPN) today announced financial results for the first half of 2017, reporting strong operating performance. 27 July 2017
Reduced growth forecasts at German life sciences group Bayer hit the company’s stocks hard on Wednesday morning, with its share price sliding by 3% to 108.65 euros in three hours after the announcement of the latest quarterly financials. 27 July 2017
Swiss pharma giant Roche this morning presented financial results for the first half of 2017, showing that sale of 26.34 billion ($27.6 billion) had risen 5%, at constant exchange rates and in Swiss franc compared with the like 2016 period. 27 July 2017
US anti-virals giant Gilead Sciences late Tuesday posted its financial results for the second quarter of 2017, showing that total revenues were down around 9% at $7.14 billion compared to $7.78 billion in the like quarter of 2016, contradicting consensus analysts’ expectations of an 18% decline. 27 July 2017
Shares in UK pharma major GlaxoSmithKline suffered a 1.5% hit in three hours, dropping to £156.35, after the company presented its second quarter 2017 results. 26 July 2017
US biotech major Amgen posted financial results for the second quarter of 2017 after the markets closed on Monday, showing that total revenues increased 2% versus the like quarter of 2016 to $5.8 billion, beating analysts’ expectations of $5.7 billion. 26 July 2017
Revenues at Almirall, Spain’s largest drugmaker, were 11.5% lower in the first half of 2017 than in the previous year, its latest financial figures show. 24 July 2017
Trying to control investor and media relations for Anglo-Swedish pharma major AstraZeneca remains an unenviable task, with leaks now appearing to suggest that chief executive Pascal Soriot is staying. 24 July 2017
The share price of Canada-based Aeterna Zentaris’ had shot up by nearly 200% to $3.01 by Friday lunchtime compared to Tuesday’s close, with the company considering what to do with new-found success. 21 July 2017
The pharmaceutical industry is one of the UK’s great success stories, writes Michael Jewell, healthcare partner at Cavendish Corporate Finance, in an Expert View piece on how the sector could see an increase in deal-making as Brexit looms. 20 July 2017
US health care giant Johnson & Johnson was 1.3% up at $133.91 on Tuesday lunchtime after investors reacted positively to the presentation of its 2nd-qtr results, although sales in its pharma segment were in fact down on a year ago. 18 July 2017
Novartis’ shares were up 2.25% at 81.95 Swiss francs in morning trading, after the company posted second-quarter 2017 financial results that beat expectations, and reiterated its forecast that sales would start growing again in 2018. 18 July 2017
Monday has been a painful day for Almirall, Spain’s largest drugmaker, which looked set to close the day’s trading having lost a quarter of its share value. 10 July 2017
UK drugmaker GlaxoSmithKline will be hoping for a stabilization in its share price on Thursday afternoon after a significant slide was started by a broker downgrading its stock recommendation. 6 July 2017
American diabetes startup Diasome Pharmaceuticals has received up to $30 million in funding from a group of four investors, led by British life science venture capitalists Medicxi. 6 July 2017
A Californian startup focused on oncology, Vivace Therapeutics, has raised $25 million in series B funding from a mainly Chinese consortium of investors. 5 July 2017
A US biotech which calls itself the pioneer of a ‘new class of extraordinarily active and differentiated cell therapies’ has raised $120 million in a highly oversubscribed private financing. 22 June 2017
In a battle which commentators might observe embodies a wider conflict of its time, the row engulfing Netherlands-incorporated drugmaker Mylan has entered another ugly round. 13 June 2017
Paris-based asset manager Kurma Partners has raised 140 million euros ($154 million), successfully completing the first closing of Biofund IV 4 October 2024
Caliway Biopharmaceuticals has successfully completed its initial public offering, raising NT$6.4 billion ($206 million), the largest IPO in Taiwan's biotech industry to date. 3 October 2024
Shares of UK drug developer Hemogenyx Pharmaceuticals rose as much as 9% and closed up 5.9% at 1.70 pence yesterday on the news of a further investment from Prevail Partners. 3 October 2024
UK-based biotech Resolution Therapeutics has announced the completion of a £63.5 million ($76.8 million) series B financing round led by Syncona. 3 October 2024
UK-based biotech LoQus23 Therapeutics has closed a £35 million ($43 million) series A financing round, led by Forbion, with support from SV Health Investors' Dementia Discovery Fund and Novartis Venture Fund. 2 October 2024
USA-based Kailera Therapeutics today announced its launch as a clinical-stage biopharmaceutical company focused on advancing a broad pipeline of next-generation therapies for the treatment of obesity and related conditions. 1 October 2024
Boston, USA-based biotech Aktis Oncology, which is targeting alpha radiopharmaceuticals to treat a broad range of solid tumors, today announced the successful closing of an oversubscribed and upsized $175 million Series B financing. 1 October 2024
Chicago, USA-based ARCH Venture Partners revealed it has closed the ARCH Venture Fund XIII, a venture capital fund with more than $3 billion to support the founding and growth of early-stage biotechnology companies. 27 September 2024
USA-based biotech funder and incubator Flagship Pioneering yesterday unveiled Mirai Bio, a company pioneering the first open end-to-end platform for the biotech industry to enable the co-creation of fully optimized genetic medicines. 27 September 2024
The UK government has released a position paper outlining its vision for Framework Programme 10 (FP10), a successor to Horizon Europe, the EU's flagship research collaboration program. 26 September 2024
Italian biotech Genespire—which is developing off-the-shelf gene therapies for pediatric patients affected by genetic diseases—has announced the closing of a 46.6 million euros ($52 million) Series B financing. 25 September 2024
Healthcare plan provider Centivo has raised $75 million in equity and debt financing to support its goal of offering affordable care to employees and their families. 25 September 2024
Rare disease firm bluebird bio has announced a company-wide restructuring aimed at cutting costs by 20% and achieving quarterly cash flow break-even by the second half of 2025. 25 September 2024
Aptadir Therapeutics, a biotech company focused on RNA inhibitor-based therapies for cancer and genetic conditions, has launched with $1.6 million in pre-seed funding. 24 September 2024
Australian biotech company Telix Pharmaceuticals is to acquire USA-based RLS Radiopharmacies, expanding its manufacturing and distribution footprint in North America. 24 September 2024
British biotech Vicebio has secured $100 million in a series B funding round to accelerate the development of its next-generation vaccines against respiratory viruses. 23 September 2024
A pre-clinical stage biopharmaceutical group developing new medicines and treatments to treat blood and autoimmune disease and to bring the curative power of bone marrow transplantation to a greater number of patients suffering from otherwise incurable life-threatening diseases.
Sign up to receive email updates Join industry leaders for a daily roundup of biotech & pharma news